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Regulation and Function of the Caspase-1 in an
Inﬂammatory Microenvironment
Dai-Jen Lee1, Fei Du1, Shih-Wei Chen1, Manando Nakasaki2, Isha Rana2, Vincent F.S. Shih3,
Alexander Hoffmann3 and Colin Jamora1,2,4
The inﬂammasome is a complex of proteins that has a critical role in mounting an inﬂammatory response in reply
to a harmful stimulus that compromises the homeostatic state of the tissue. The NLRP3 inﬂammasome, which is
found in a wound-like environment, is comprised of three components: the NLRP3, the adaptor protein ASC and
caspase-1. Interestingly, although ASC levels do not ﬂuctuate, caspase-1 levels are elevated in both physiological
and pathological conditions. Despite the observation that merely raising caspase-1 levels is sufﬁcient to induce
inﬂammation, the crucial question regarding the mechanism governing its expression is unexplored. We found
that, in an inﬂammatory microenvironment, caspase-1 is regulated by NF-κB. Consistent with this association, the
inhibition of caspase-1 activity parallels the effects on wound healing caused by the abrogation of NF-κB
activation. Surprisingly, not only does inhibition of the NF-κB/caspase-1 axis disrupt the inﬂammatory phase of
the wound-healing program, but it also impairs the stimulation of cutaneous epithelial stem cells of the
proliferative phase. These data provide a mechanistic basis for the complex interplay between different phases of
the wound-healing response in which the downstream signaling activity of immune cells can kindle the
ampliﬁcation of local stem cells to advance tissue repair.
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INTRODUCTION
The major function of the skin is to provide a physical barrier
between the body and the external environment. Conse-
quently, it is frequently damaged and mounts a complex
wound-healing program to restore tissue homeostasis. This
wound-healing response is organized into three interdepen-
dent phases: an inﬂammatory phase leading to the recruit-
ment and activation of immune cells; a proliferative phase
comprising the expansion of the progenitor cell pool,
angiogenesis, and re-epithelialization (migration of keratino-
cytes to close the wound); and the remodeling phase wherein
alterations in tissue architecture and the extracellular matrix
are carried out (Gurtner et al., 2008). Hindering the mech-
anistic understanding of this process is the fact that signaling
by cells in one phase of the wound-healing program impacts
the behavior of cells associated with another phase.
In response to many different external stimuli, inﬂammation
can be mediated by a multiprotein complex known as an
inﬂammasome, which promotes the maturation and secretion
of proinﬂammatory cytokines. The inﬂammasome can be
comprised of an NLR (nucleotide-binding domain and leucine-
rich repeat containing) protein, an adaptor protein ASC
(apoptosis-associated speck-like protein), and procaspase-1.
The NLR proteins are a family of intracellular sensors that can
detect the presence of pathogens and also recognize danger
or stress signals (Schroder and Tschopp, 2010). Whereas the
levels of the adaptor protein ASC remains unchanged, we
found that the stress kinase p38 mitogen-activated protein
kinase (MAPK) is responsible for the upregulation of NLRP3 in
a wound-like environment (Lee et al., 2009), but the regulation
of caspase-1 expression remains poorly understood.
Caspase-1 is a cysteine protease that is synthesized as a
zymogen. The assembly of NRLP3 inﬂammasome induces the
cleavage and activation of procaspase-1, which can then
process IL-1 family members such as IL-1α (Keller et al.,
2008), IL-1β, and IL-18 into their mature forms (Yu and Finlay,
2008). In the context of wounding (Lee et al., 2009), as well
as diseases with chronic inﬂammation such as psoriasis
(Johansen et al., 2007), heart disease (Merkle et al., 2007),
gout, and arthritis (Church et al., 2008), there is an upre-
gulation of procaspase-1 expression. Despite these observa-
tions, both the mechanism and the functional relevance of
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increasing the expression of procaspase-1 have failed to
garner much attention. A clue to the importance of the
upregulation of procaspase-1 was the development of cuta-
neous inﬂammation simply by overexpressing procaspase-1
in epidermal keratinocytes (Yamanaka et al., 2000).
A prime candidate for the transcriptional regulator of
caspase-1 is the transcription factor NF-κB, a well-known
mediator of the inﬂammatory response (Karin, 2009). This
dimeric complex is sequestered in the cytosol via its asso-
ciation with IκB. Activation of NF-κB is accomplished through
the IκB kinase (IKK), which can phosphorylate IκB and lead to
its dissociation from NF-κB. Upon activation, NF-κB dimers
are translocated into the nucleus where they modulate
the expression of numerous genes involved in the immune
response. To investigate the potential link between NF-κB and
caspase-1 in restoring tissue homeostasis, we exploited the
conditional deletion of epidermal caspase-8 (C8cKO) as a
model of wound healing and in which caspase-1 levels are
elevated throughout the epidermis (Lee et al., 2009).
RESULTS
The expression of caspase-1 is regulated by NF-κB
To test the hypothesis that NF-κB regulates procaspase-1
expression, epidermal explants from wild-type and caspase-8
conditional knockout (C8KO) mice were treated with DMSO
(vehicle control) or a pharmacological inhibitor of NF-κB
activation. Inhibition of NF-κB activation was accomplished
with a chemical inhibitor of the upstream activator of NF-κB
(IKK inhibitor (IKK-I)). In the C8KO epidermis, the increased
procaspase-1 is diminished to near wild-type levels by the
treatment with IKK-I at both the RNA (Figure 1a) and the
protein level. This effect is both dose dependent (Supple-
mentary Figure 1 online) and reversible (Figure 1a). Interest-
ingly, IKK-I did not affect the expression of NLRP3 despite
suggestions to the contrary (Bauernfeind et al., 2009;
Figure 1b). On the other hand, p38 MAPK regulates NLRP3
in the wound-like epidermis (Figure 1b) but did not affect the
increase in procaspase-1 (Figure 1a). The third component of
many NLRP3-containing inﬂammasomes is ASC, whose levels
were constant in wild-type and C8KO epidermis (Figure 1c).
Altogether, these inhibitor studies suggest that expression of
the components of the NLRP3 inﬂammasome is under the
regulation of at least two convergent signaling pathways—
p38 MAPK regulates NLRP3 expression, whereas NF-κB
controls the expression of procaspase-1.
In order to examine whether NF-κB activity is sufﬁcient
to induce procaspase-1, we utilized newborn epidermal
explants lacking Iκbα, a negative regulator of NF-κB. The
basal level of NF-κB activity in wild-type and Iκbα knockout
mice is the same, but there is a prolonged activation of NF-κB
signaling with a pulse of a stimulus such as IL-1 or tumor
necrosis factor in iκbα-null cells (Klement et al., 1996).
Approximately 13-fold increase in the level of a bona ﬁde NF-
κB target gene, RANTES, veriﬁed that the loss of Iκbα induces
an extended activation of NF-κB signaling in epidermal
explants (Supplementary Figure 2 online).
Under these conditions, procaspase-1 expression remains
~ 70-fold higher in the Iκbα knockout epidermis relative to the
wild-type control (Figure 1d), but there is no appreciable
effect on NLRP3 or ASC (data not shown). Interestingly,
despite the ~ 70-fold increase in caspase-1 RNA levels in the
iκbα KO relative to the wild-type control, the increase
in caspase-8 protein level, although signiﬁcant, was only
~ 4-fold. Secreted IL-1α is not only the product of caspase-1
activity but is also involved in a positive feedback loop to
activate NF-κB in an autocrine or a paracrine manner
(Vallabhapurapu and Karin, 2009). In order to determine
how much of the increase in caspase-1 expression is due to
this positive feedback loop, we tested the effect of blocking
the signaling of IL-1α with a neutralizing antibody.
Neutralizing extracellular IL-1α markedly reduces the
induction of procaspase-1 expression in the iκbα null back-
ground (Figure 1d). The remaining ~ 15-fold increase in
caspase-1 levels in the iκbα knockout epidermis may reﬂect
the direct intracellular signaling events linking NF-κB to
caspase-1. This theory was substantiated by the effect of the
caspase-1 inhibitor, which would effectively short circuit the
positive feedback loop resulting from the caspase-1-
dependent secretion of IL-1α. The treatment of iκbα-null
epidermis with the caspase-1 inhibitor likewise results in a
~15-fold difference in caspase-1 RNA levels compared with
the wild-type explants (Figure 1d). The decrease in caspase-1
expression by the IL-1α inhibitor antibody or the caspase-1
inhibitor in the iκbα KO skin is also reﬂected at the protein
level (Figure 1d).
Reconstitution of caspase-1 regulatory control in vitro
In contrast to the heterogeneous population of cells that
comprise the epidermis used above, we investigated whether
the NF-κB–caspase-1 relationship is valid within wounded
epidermal keratinocytes in vitro. Sixteen hours after applying
a scratch wound on a conﬂuent sheet of keratinocytes, a
decrease in caspase-8 protein levels was only observed in
cells migrating from the wound edge (Figure 2a). This
occurred in tandem with the activation of NF-κB (Figure 2b
and Supplementary Figure 3A online). Consistent with our
proposed pathway, the decrease in caspase-8 in epidermal
keratinocytes leading to the activation of NF-κB resulted in an
increase in caspase-1 expression (Figure 2c and Supple-
mentary Figure 3B online). Interestingly, the increase in
caspase-1 protein levels was observed in both the cytosol and
the nucleus of the migrating cells (Supplementary Figure 3C
and D online). This nuclear translocation of caspase-1 has
previously been described upon exposure of cells to tumor
necrosis factor (Mao et al., 1998), although the function
remains unknown. We then examined whether activation of
NF-κB is sufﬁcient to induce caspase-1 expression in vitro by
transfecting primary keratinocytes with a constitutively active
mutant of IKK2 (IKK2-CA). Twelve hours after transfection,
about 10% of the cultured cells expressed the IKK2-CA
construct leading to the activation of NF-κB (Figure 2d and
Supplementary Figure 3E online) and ~2.5-fold increase in
caspase-1 RNA (Figure 2e) and protein (Supplementary Figure
3F online) expression. Moreover, activation of NF-κB with
IL-1α can elevate the amount of procaspase-1 protein, and
this effect can be blocked by inhibiting NF-κB activation with
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the IKK-I or with glyburide, which blocks the inﬂammasome
function (Figure 2f and Supplementary Figure 3G online).
These results provide evidence that NF-κB is involved in the
regulation of caspase-1 expression, but it is unclear whether
NF-κB is the direct upstream transcriptional activator.
To address this question, we cloned a 1 kb fragment of the
proximal promoter of caspase-1, which contains a conserved
NF-κB-binding motif (Supplementary Figure 4A online), and
found that mutating this consensus sequence signiﬁcantly
reduced the ability of active NF-κB to induce caspase-1
transcription (Supplementary Figure 4B online). Moreover, we
tested whether this likewise occurs on the conserved motif on
the endogenous caspase-1 promoter in primary keratinocytes
via chromatin immunoprecipitation. After a 4-hour stimula-
tion with IL-1α (Supplementary Figure 4C online), we were
able to co-precipitate the NF-κB-binding motif of the caspase-
1 promoter with the p65 subunit of the NF-κB complex
(Figure 2g), suggesting that this transcription factor is a direct
activator of caspase-1 expression.
Caspase-1 ampliﬁes NF-κB signaling in the epidermis
Upon establishing the NF-κB/caspase-1 regulatory relation-
ship in vitro, we then focused our attention on its regulation
and function within a tissue. We incubated wild-type or
C8KO epidermal explants in media with vehicle control
(DMSO) or IKK-I and assayed for the amount of secreted IL-1,
which is a readout for activated caspase-1. We previously
found that the levels of IL-1α in the C8KO skin is higher than
wild type, but its secretion was still dependent on caspase-1
activity (Lee et al., 2009). Reducing caspase-1 expression in
the C8KO epidermis through the inhibition of NF-κB also
reduces the secretion of IL- 1α to wild-type levels (Figure 3a).
This occurs concomitant with a blockage of proteo-
lytic cleavage of caspase-1 into its active p20 fragment
(Supplementary Figure 5A online). Furthermore, we observed
that the prolonged activity of NF-κB in the IκBα-deﬁcient
epidermis results in the higher expression of procaspase-1
(Figure 1d), prompting us to examine whether this likewise
translates into an increase in IL-1α secretion. The prolonged
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Figure 1. NF-κB regulates caspase-1 expression. Epidermal explants from wild-type (WT) and caspase-8 knockout (C8KO) mice were treated with DMSO, or
inhibitors for p38 MAPK (p38-I) or IKK (IKK-I) and qPCR and western blots were performed for (a) caspase-1, (b) NLRP3, and (c) ASC expression. (d) qPCR of
caspase-1 expression in the epidermis of newborn wild-type or iκbα knockout mice treated with DMSO, IL-1α inhibitory antibody (IL-1α inhi. Ab), or caspase-1
inhibitor (C1-I). For all experiments n=5 biological replicates, and each sample was run in triplicate for qPCR; error bars are SEM, *denotes Po0.001, and
**denotes Po0.00001. β-tubulin level was used as a loading control for western blots. WO, inhibitor washed-out.
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NF-κB signaling in the IκBα KO resulted in a substantial
increase in activated caspase-1 (Supplementary Figure 5B
online) and in IL-1α secretion (Figure 3b) compared with the
wild-type epidermis. Reducing the activity of caspase-1 in the
IκBα-knockout epidermis (Supplementary Figure 5B online)
markedly reduced the amount of secreted IL-1α (Figure 3b).
This effect of activated NF-κB on raising IL-1α secretion can
be reconstituted in vitro by transfecting keratinocytes with the
IKK2-CA construct (Figure 3c). Moreover, pharmacological
inhibition of caspase-1 activity can also abrogate the
stimulation of IL-1α secretion. The secretion of IL-1α has
been shown to be dependent upon caspase-1 activity (Keller
et al., 2008), and the NF-κB–caspase-1 signaling pathway also
yields similar results when tested on the intracellular levels of
IL-1α (Supplementary Figure 5C–F online), as well as the
secretion of IL-1β, a classical readout of caspase-1 function
(Supplementary Figure 5G–I online).
The ability of IL-1α ligand to activate NF-κB suggests that
the release of this cytokine can propagate the NF-κB–caspase-
1–IL-1α module throughout the epidermis via a paracrine
effect. We found that removal of the IL-1 receptor in the
wound model diminished the level of secreted IL-1α
compared with the C8cKO epidermis (Figure 3d). We further
tested this paracrine model by transfecting primary keratino-
cytes with the IKK2-CA. As we have shown, keratinocytes
expressing IKK2-CA displayed nuclear NF-κB 12 hours after
transfection (Figure 2d). However, when we allowed the cells
to incubate longer (~24 hours), cells adjacent to the
transfected cells were induced to activate NF-κB (Figure 3e).
Use of the IL-1α-neutralizing antibody or the caspase-1
inhibitor restricted NF-κB activation solely to cells transfected
with IKK2-CA.
To test whether this is also valid in wound-like conditions
in vivo, we subcutaneously injected vehicle control (DMSO)
or IKK-I daily in the back skin of newborn wild-type or C8cKO
mice for 4 days. Inhibition of NF-κB activation, which blocks
IL-1α release (Figure 3a), suppresses the expression of active
NF-κB throughout the epidermis, although the dermal
activation of NF-κB is largely unaffected (Figure 4a). This
block in epidermal activation of NF-κB was also present when
excisional wounds were treated with IKK-I (Supplementary
Figure 6 online). Moreover, genetic removal of caspase-1
expression from the C8cKO epidermis (Figure 4b and c)
likewise reduces the expression of active NF-κB throughout
the epidermis.
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Figure 2. Regulation of caspase-1 by NF-κB in wounded cells. (a) Immunoﬂuorescence of (a) caspase-8 (red), DAPI (blue), and (b) NF-κB (green) in primary
keratinocytes after 8 or 16 hours of applying a scratch wound (dotted line denotes wound margin). Right panels in b are the magniﬁed views of the boxed areas in
the left panels. (c) qPCR of caspase-1 RNA levels at 0 and 16 hours after applying scratch wound. (d) Primary keratinocytes were transfected with constitutively
active HA-tagged IKK2 (HA-IKK2-CA) and stained for active IKK2 (red) and NF-κB (green) or caspase-1 (green). Cells expressing IKK2 have nuclear NF-κB and
higher levels of caspase-1. (e) qPCR of relative levels of caspase-1 RNA in keratinocytes transfected with empty vector (Con; normalized to 1) or IKK2-CA.
(f) Relative caspase-1 protein levels in keratinocytes exposed to IL-1 and DMSO, IKK-I, or glyburide. Caspase-1 protein levels in cells without IL-1α stimulation is
normalized to 1, and data are presented as fold difference. Data are the mean of three biological replicates, and error bars are SEM. (g) ChIP of NF-κB upon
stimulation with IL-1α and immunoprecipitation with IgG control antibody or an antibody recognizing the p65 subunit of NF-κB. *indicates Po0.001. For qPCR
experiments (c and e), results are from three biological replicates with each PCR reaction performed in triplicate (error bars are SEM).
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As the inhibition of NF-κB activity and caspase-1 expres-
sion both prevented the spreading of active NF-κB in the
C8cKO epidermis, we predicted that the expression of
caspase-1 would likewise be adversely affected. Caspase-1
is expressed at a low basal level in wild-type epidermis, is
signiﬁcantly upregulated in the C8cKO tissue, and this induc-
tion is lost in the presence of IKK-I (Figure 4d). Interestingly,
application of a pharmacological inhibitor of caspase-1
activity results in a marked reduction in the expression of
caspase-1 throughout the tissue, and the remaining protein is
restricted to the upper layers of the epidermis (Figure 4d).
Moreover, in the absence of IL-1 signaling, caspase-1 expres-
sion is not highly induced in the C8cKO epidermis (Figure 4e).
Therefore, abrogation of NF-κB activation inhibits the
upregulation of caspase-1 expression and inhibition of the
latter’s proteolytic activity can effectively block the spreading
of NF-κB and caspase-1 expression from the surface of the
epidermis to the lower layers of this tissue, which occurs
through IL-1 paracrine signaling.
Inhibition of NF-κB and caspase-1 delays wound closure rates
We then focused our attention on the functional contribution
of these proteins to the wound-healing response. Excisional
wounds were made on the back of wild-type mice treated
with DMSO or IKK-I, caspase-1 knockout mice, and IL-1R KO
mice (Figure 5). Interestingly, inhibition of NF-κB activation or
caspase-1 expression signiﬁcantly delayed the closure rate of
an excisional wound compared with control samples
(Figure 5a). This delay in wound closure by 2 or more
days parallels the effects seen when other important factors
for wound healing are deleted (Devalaraja et al., 2000;
Echtermeyer et al., 2001; Jameson et al., 2002). We veriﬁed
that both the inhibition of NF-κB activation and caspase-1
expression indeed impacted inﬂammation as they were able
to decrease the recruitment of immune cells to the skin. For
instance, the number of macrophages and T cells recruited to
the skin in the C8cKO (Figure 5b and c) or to wounded skin
(Supplementary Figure 7A and B online) is severely reduced
when NF-κB activity or caspase-1 expression is suppressed.
The failure to recruit immune cells to the skin under these
conditions is also reﬂected in the diminished expression of
inﬂammatory genes (Figure 5d). Together, these data highlight
the critical role for the NF-κB/caspase-1/IL-1 axis in the
establishment of the inﬂammatory phase of the cutaneous
wound-healing response.
NF-κB/caspase-1 signaling affects proliferation during the
wound-healing response
Closer examination of the effects of the NF-κB and caspase-1
inhibition on the rate of wound closure reveals an affect
during the proliferative phase of the wound response, which
commences around day 3 post wounding. This effect may be
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Figure 3. Caspase-1 propagates NF-κB signaling in epidermal keratinocytes. Secretion of IL-1α was measured by ELISA from different samples: (a) Wild-type
(orange bars) or caspase–8–null (C8KO; blue bars) epidermis treated with DMSO or IKK-I; (b) wild-type or iκbα-null (purple bars) epidermis treated with DMSO or
C1-I; (c) primary keratinocytes transfected with empty vector (control), IKK2-CA, or IKK2-CA and treated with C1-I; (d) the epidermis from wild-type, caspase-8–
null, and caspase-8/IL-1R double knockout mice. ELISA results are the mean of three biological replicates, and error bars are SEM. *denotes Po0.001; **denotes
Po0.00001. (e) Primary keratinocytes were transfected with constitutively active IKK2 (HA-IKK2-CA) and treated with DMSO (control), IL-1α inhibitory antibody,
or caspase-1 inhibitor (C1-I) and stained for IKK2-CA (red) and NF-κB (green). Data are representative of three independent experiments.
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attributable to the role that NF-κB and caspase-1 have in the
secretion of IL-1. We previously demonstrated that the
IL-1–mediated epithelial–mesenchymal signaling loop that
stimulates keratinocytes proliferation in a wound is recapitu-
lated in the C8cKO model (Lee et al., 2009). One outcome of
this pro-proliferation signaling network is the thickening of the
epidermis (epidermal hyperplasia).
Consistent with this model, inhibition of NF-κB activation
or loss of caspase-1 expression in the C8cKO skin signiﬁ-
cantly reduced epidermal hyperplasia (Figure 6a and
Supplementary Figure 8A online). This phenomenon was also
seen in response to excisional wounds (Supplementary Figure
8B online). The thickening of the epidermis in the C8cKO
mouse is fueled by an increase in the number of proliferating
progenitor cells found in the basal layer of the epidermis and
the hair follicle (Figure 6b). Both are reduced in the presence
of the inhibitor of NF-κB activation or loss of caspase-1
expression (Figure 6b–d). However, these effects are not
applicable to all the phenomena associated with the prolife-
rative phase of the wound-healing response. For instance,
new blood vessel formation is a feature of this phase of the
wound-healing program, but the injection of IKK-I or the loss
of caspase-1 expression do not qualitatively decrease angio-
genesis in the skin (Figure 6e). Altogether, these observations
link a functional inﬂammatory phase of the wound-healing
response with the optimal stimulation of cell proliferation that
occurs during a wound-healing response.
DISCUSSION
A major obstacle to understanding wound healing is the
untangling of the extensive interdependence of the three
classical phases of this process. Using the ablation of
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epidermal caspase-8 as a model of wound healing, we have
uncovered a molecular mechanism synchronizing these
complex reactions. Upon wounding, caspase-8, which
normally resides in the granular layer near the surface of the
epidermis, is downregulated and initiates a biochemical pro-
gram to promote tissue repair (Lee et al., 2009). One effect of
this downregulation is the increase in IL-1α RNA expression,
as well as the release of the preexisting reservoir of this
cytokine from epidermal keratinocytes (Lee et al., 2009). IL-1α
has a plethora of effects ranging from the promotion of an
inﬂammatory microenvironment to promoting a growth arrest
and survival model in suprabasal keratinocytes to the
stimulation of stem cell proliferation. Given the profound
impact of IL-1α signaling in the framework of wound healing,
the mechanism governing its release is an important issue to
resolve. We found that at least two different signaling pathways
impact the components of the NLRP3 inﬂammasome—p38
MAPK regulates NLRP3 expression (Lee et al., 2009) and
NF-κB inﬂuences caspase-1 expression levels (Supplementary
Figure 9 online).
Together, these pathways lead to IL-1α secretion that can
operate in an autocrine manner to potentiate the NF-κB
signaling cascade or function in a paracrine manner to
propagate the NF-κB signaling to different layers of keratino-
cytes in the epidermis. This exempliﬁes the central and
complex role that IL-1α and NF-κB have in regulating
epithelial homeostasis (Swamy et al., 2010).
Recently, however, work from David Wallach’s group has
raised doubts about the role of IL-1α in mediating inﬂamma-
tion in the epidermal C8cKO mouse (Kovalenko et al., 2009).
This is based on their ﬁnding that genetic ablation of both
IL-1α and IL-1β did not abrogate the cutaneous inﬂammation
stimulated by the loss of epidermal caspase-8. However, as
we observed, removal of one signaling pathway such as IL-1
can delay the kinetics of wound closure but not completely
abrogate it. The ⩾ 2-day delay in wound healing by blocking
components of the NF-κB/caspase-1/IL-1 axis is consistent
with the delay in wound healing found when other important
components are deleted such as γδ T cells (Jameson et al.,
2002), syndecan-4 (Echtermeyer et al., 2001), and CXCR2
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Figure 5. Effect of NF-κB and caspase-1 on wound closure. (a) Rates of wound closure were measured in wild-type mice treated daily with DMSO or IKK-I or in
mutant mice lacking either caspase-1 (C1KO) or IL-1 receptor (IL-1RKO). Data points are averages of six mice with two wounds per mouse (*denotes Po0.001;
**denotes Po0.00001 when comparing DMSO versus IKK-I kinetics in wild-type mice). (b) Recruitment of macrophages (green) in the wild-type and caspase-8–
null skin treated with DMSO (control) or IKK-I or in the skin lacking caspase-1 and -8. (c) Recruitment of T cells (green) monitored using the pan T-cell marker
CD3. The epidermis (epi) and hair follicles (hf) in b and c are noted in red with an antibody detecting keratin-5. Bar = 50 μm; der, dermis; (d) Inﬂammatory gene
expression in the wounded/wound-like skin. RNA was extracted from the wounded skin of wild-type mice (treated with DMSO (orange bars) or IKK-I (yellow
bars)) or caspase-1 KO mice (C1KO; red bars) 3 days post-excisional wounding. RNA was also extracted from the skin of P5 caspase-8 knockout (C8KO) mice
(treated with DMSO (blue) or IKK-I (light blue)) or the caspase-8/caspase-1 (C1KO) double knockout mouse (magenta). Results are from three biological replicates
for each mouse genotype/treatment, and each sample was repeated in triplicate. Error bars are SEM. der, dermis.
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(Devalaraja et al., 2000). We also observed that the C8cKO/
IL-1 receptor double knockout transiently dampens the
phenotype of the C8cKO mouse, which is likely owing to
the fact that other components in the inﬂammatory phase can
compensate for the loss of one constituent. Further support for
IL-1 signaling in a wound-like environment is provided by the
ﬁnding of increased nuclear NF-κB when the IL-1 receptor
antagonist is missing (Ishida et al., 2006). Thus, we propose
that the large reservoir of IL-1α released from damaged
keratinocytes is among the earliest responders to epidermal
trauma to stimulate the wound-healing response. In particular,
IL-1α can induce the inﬂammatory phase and thereby
promote the proliferative phase, and this role is assumed by
inﬁltrating immune cells, which secretes the more potent
IL-1β.
An important question that arises from our model is the link
between the downregulation of caspase-8 and the activation
of NF-κB prior to the positive feedback loop mediated by
IL-1α secretion. Of particular relevance are reports that
deletion of RIP3 rescues the caspase-8 knockout phenotype,
including cutaneous inﬂammation (Gunther et al., 2011;
Kaiser et al., 2011; Welz et al., 2011). Interestingly, more
recent studies have demonstrated that RIP3 can also activate
NLRP3 and caspase-1 (Vince et al., 2012; Kang et al., 2013).
Thus, the loss of caspase-8 may liberate RIP3 to interact with
different partners to stimulate inﬂammasome activation.
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Further delineating the details of inﬂammasome activation
will contribute important new insights on how to combat
inﬂammatory diseases when these signaling pathways are
perturbed.
MATERIALS AND METHODS
Reagents
The list of antibodies, inhibitors, and primers and their usage are
detailed in the Supplementary Information Section online.
Mice and cell/tissue culture
Generation of C8KO (Lee et al., 2009) and iκbα KO (Klement et al.,
1996) mice has previously been reported. Wild-type primary mouse
keratinocytes are obtained from the epidermis of newborn pups and
cultured in low-calcium mouse keratinocyte media as described
previously (Lee et al., 2009). Epidermal explants were taken from
P0-P3 skin by chemically dissociating it from the dermis with
dispase for 1 hour at 37 °C. All animal work was carried out in
accordance with the policies and approved procedures of the
Institutional Animal Care and Use Committee of University of
California San Diego.
Tissue preparation
Epidermal explants were incubated with p38-I and IKK-I overnight
and collected in Trizol (Invitrogen) for RNA extraction or in sample
buffer for protein extraction. The wash-out of IKK-I-treated epidermis
was carried out by washing with phosphate-buffered saline once and
transferred to fresh mouse keratinocyte media and incubated for
another 6 hours. Glyburide was incubated with the epidermis for
1 hour and transferred to fresh media with glyburide for another hour.
IL-1α (2 ng μl−1) was added to WT and iκbα KO epidermis for
2 hours and replaced with fresh media and incubated for another
6 hours prior to sample collection.
Wounding and injection of mice
DMSO, IKK-I, and caspase-1 inhibitor were injected into the back
skin of WT and C8KO mice daily for 4 days starting at P0 prior to the
onset of the phenotype, and the back skin was collected on the 5th
day for RNA extraction and OCT embedding. In vivo wounding was
performed on the back skin of adult wild-type mice with 5mm-punch
biopsy, and DMSO and inhibitors were applied to the wound site
daily for 3 days. Wounded skin was collected for RNA extraction and
OCT embedding. Data presented are averages of two wounds per
mouse (n= 6 mice± SEM) for each treatment. For in vitro scratch
wounds, primary mouse keratinocytes were cultured on coverslips to
conﬂuency. The scratch wound was performed on the cell
monolayer with a p200 pipet tip. Cells were incubated at 37 °C for
up to 16 hours and then ﬁxed for immunoﬂuorescence or collected
for RNA extraction.
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